Covidien has obtained the US Food and Drug Administration (FDA) 510(k) clearance for LigaSure Curved, Small Jaw, Open Sealer/Divider surgical instrument, for use in general surgery.
The LigaSure Curved, Small Jaw, Open Sealer/Divider, the latest addition to the Covidien‘s LigaSure family of advanced surgical cutting/sealing devices, provides an integrated cutting mechanism independent of sealing, leaving the critical cutting decisions in the hands of the surgeon.
The instrument’s multi-functional design also provides for blunt dissection and an enhanced and efficient experience for the surgeon, in confined surgical spaces.
The new LigaSure device has a primary feature of a low-temperature profile and minimal thermal spread to surrounding tissues.
The LigaSure technology, powered by the ForceTriad energy platform, provides surgeons with a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls.